FDA Blocked Studies Finding Covid, Shingles Vaccines Safe
Agency scientists found serious side effects were rare, but top officials blocked release of studies on millions of vaccine recipients.
- The U.S. Food and Drug Administration blocked publication of multiple safety studies on Covid and shingles vaccines, which found serious side effects to be very rare, according to a Health and Human Services spokesperson.
- Under Health and Human Services Secretary Robert F. Kennedy Jr.'s leadership, federal agencies have softened Covid shot recommendations and reduced vaccine research, including blocking information supporting vaccine safety.
- Several Covid vaccine safety studies accepted by medical journals were withdrawn, and abstracts on the shingles vaccine Shingrix were not approved for submission to a drug safety conference.
- FDA officials stated that some studies were withdrawn due to authors drawing broad conclusions unsupported by data, with the shingles study's design falling outside the agency's purview.
51 Articles
51 Articles
Advocates Demand Reversal of Trump FDA's 'Appalling' Censorship of Vaccine Studies
"Suppressing scientific research exposes the absurdity of Kennedy’s frequently repeated claim that he would bring ‘gold standard’ science and ‘radical transparency’ to the nation’s public health agencies."
HHS decision to block vaccine studies on COVID and shingles draws 'black box' criticism
Health experts criticized the Department of Health and Human Services this week, after the agency confirmed the FDA recently blocked the publication of multiple studies supporting the safety of COVID and shingles vaccines."It's this opacity, this black box of how these decisions are getting made that I think is really worrisome and Americans really deserve better," said Dr. Jeanne Marrazzo, CEO of the Infectious Disease Society of America.FDA sc…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





















